Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 5/20 | 0.44 |
| ▸ | NPC1 | O15118 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6329754 | 0.88 | NPC1 (0.40) | RAB9ANPC1KDM4ELMNAGAA | |
| SCHEMBL6332321 | 0.85 | NPC1 (0.68) | RAB9ANPC1LMNANPSR1POLB | |
| SCHEMBL6328266 | 0.78 | NPC1 (0.64) | GLARAB9ANPC1KDM4ELMNA | |
| SCHEMBL6329857 | 0.78 | SIRT2 (0.44) | RAB9ANPC1LMNANPSR1GAA | |
| SCHEMBL6328257 | 0.78 | HPGDS (0.46) | RAB9ANPC1KDM4ETRPV1MEN1 | |
| SCHEMBL6327513 | 0.78 | RAB9A (0.69) | RAB9ANPC1KDM4ELMNANPSR1 | |
| SCHEMBL6330501 | 0.78 | NAMPT (0.50) | RAB9ANPC1KDM4ELMNAGAA | |
| SCHEMBL6329226 | 0.77 | HPGDS (0.47) | RAB9ANPC1GAATRPV1MEN1 | |
| SCHEMBL6332102 | 0.77 | PDE4D (0.58) | RAB9ANPC1KDM4EGAAMEN1 | |
| SCHEMBL7258009 | 0.76 | MAPK1 (0.46) | RAB9ANPC1KDM4ELMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6949654-B2 | N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses | SAM-SUNG ELECTRONICS CO., LTD. (KR) | 2005-09-27 | — | — | US | claimed |
| US-6949654-B2 | N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses | SAM-SUNG ELECTRONICS CO., LTD. (KR) | 2005-09-27 | — | — | US | disclosed |
| US-20030225087-A1 | N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses | SAM-SUNG ELECTRONICS CO., LTD. (KR) | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225087-A1 | N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses | SOD1, LPO, BAD | GLA 1557/4885RAB9A 539/4885NPC1 322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.